Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions
Yıl: 2020 Cilt: 25 Sayı: 2 Sayfa Aralığı: 299 - 304 Metin Dili: İngilizce DOI: 10.5505/ejm.2020.21548 İndeks Tarihi: 29-07-2022
Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions
Öz: In this study, we aimed to evaluate the Pap-smear results and colposcopic findings of 163 patients admitted to the colposcopy unit of our hospital with the histopathological examination results of cervical sampling for abnormal Pap-smear and/or colposcopy findings in the absence of HPV test.All patients underwent gynaecological examination, and Pap-smear test was performed. Subsequently, the cervix was examined by colposcopy. Local medical treatment, Pap-smear follow up, cervical sampling or surgery was recommended according to Pap-smear, colposcopic examination results and other clinical examination findings.Negative predictive value (NPV), positive predictive value (PPV), sensitivity and specificity of Pap-smear were 88.1%, 13.3%, 28.5% and 74%, respectively. NPV, PPV, sensitivity and specificity of colposcopy were 93.3%, 14.3%, 85.7 and 76.2%, respectively.The combined use of Pap-smear and colposcopy in the detection of premalignant and malignant lesions of the cervix increases the success and enables early diagnosis and appropriate treatment in the absence of HPV test.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. J BUON 2016; 21: 320-325.
- Basu P, Taghavi K, Hu SY, Mogri S, Joshi S. Management of cervical premalignant lesions. Curr Probl Cancer 2018; 42: 129-136.
- Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2017; 67: 100-121.
- Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol 2015; 123: 271-281.
- Chase DM, Kalouyan M, DiSaia PJ. Colposcopy to evaluate abnormal cervical cytology in 2008. Am J Obstet Gynecol 2009; 200: 472-480.
- Trimble CL, Genkinger JM, Burke AE, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 2005; 105: 174-181.
- Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 2004; 191: 105-113.
- Cheng JX, Yao LL, Xiang H, et al. Cervical cytology ASCUS patients with HPV detection and clinical value. Clin Exp Obstet Gynecol 2016; 43: 592-596.
- Bornstein J, Bentley J, Bösze P, et al. 2011 colposcopic terminology of the International Federation for Cervical Patholgy and Colposcopy. Obstet Gynecol 2012; 120: 166-172.
- MacLean AB. Acetowhite epithelium. Gynecol Oncol 2004; 95: 691-694.
- Jahic M, Jahic E. Diagnostic Approach to Patients with Atypical Squamous Cells of Undetermined Significance Cytologic Findings on Cervix. Med Arch 2016; 70: 296-298.
- Yang M, Zachariah S. ASCUS on cervical cytologic smears. Clinical significance. J Reprod Med 1997; 42: 329-331.
- Rojsangruang S. Prevalence of Abnormal Cervical Cytology based on the Bethesda System, at Phetchabun Hospital. J Health Sci 2006; 15: 67-74.
- Sankaranarayanan R, Thara S, Sharma A, et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 2004; 11: 77-84.
- Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995; 141: 680-689.
- Ghaemmaghami F, Behtash N, Modares Gilani M, Mousavi A, Marjani M, Moghimi R. Visual inspection with acetic acid as a feasible screening test for cervical neoplasia in Iran. Int J Gynecol Cancer 2004; 14: 465-469.
- Rieck GC, Bhaumik J, Beer HR, Leeson SC. Repeating cytology at initial colposcopy does not improve detection of high-grade abnormalities: a retrospective cohort study of 6595 women. Gynecol Oncol 2006; 101: 28-33.
- Taylor RR, Guerrieri JP, Nash JD, Henry MR, O'Connor DM. Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. J Reprod Med 1993; 38: 443-447.
- Kohli M, Ferko N, Martin A, et al. Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK. Br J Cancer 2007; 96: 143-150.
- Živadinović R, Radović M, Lilić V, Petrić S. Grading the severity of preinvasive changes of the uterine cervix by colposcopy and exfoliating cytology. FACTA UNIVERSITATIS: Medicine and Biology 2005; 12: 55-59.
- Wu S, Meng L, Wang S, Ma D. A comparison of four screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005; 91: 189-193.
| APA | Oglak S, obut m (2020). Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. , 299 - 304. 10.5505/ejm.2020.21548 |
| Chicago | Oglak Süleyman Cemil,obut mehmet Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. (2020): 299 - 304. 10.5505/ejm.2020.21548 |
| MLA | Oglak Süleyman Cemil,obut mehmet Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. , 2020, ss.299 - 304. 10.5505/ejm.2020.21548 |
| AMA | Oglak S,obut m Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. . 2020; 299 - 304. 10.5505/ejm.2020.21548 |
| Vancouver | Oglak S,obut m Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. . 2020; 299 - 304. 10.5505/ejm.2020.21548 |
| IEEE | Oglak S,obut m "Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions." , ss.299 - 304, 2020. 10.5505/ejm.2020.21548 |
| ISNAD | Oglak, Süleyman Cemil - obut, mehmet. "Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions". (2020), 299-304. https://doi.org/10.5505/ejm.2020.21548 |
| APA | Oglak S, obut m (2020). Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. Eastern Journal of Medicine, 25(2), 299 - 304. 10.5505/ejm.2020.21548 |
| Chicago | Oglak Süleyman Cemil,obut mehmet Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. Eastern Journal of Medicine 25, no.2 (2020): 299 - 304. 10.5505/ejm.2020.21548 |
| MLA | Oglak Süleyman Cemil,obut mehmet Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. Eastern Journal of Medicine, vol.25, no.2, 2020, ss.299 - 304. 10.5505/ejm.2020.21548 |
| AMA | Oglak S,obut m Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. Eastern Journal of Medicine. 2020; 25(2): 299 - 304. 10.5505/ejm.2020.21548 |
| Vancouver | Oglak S,obut m Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions. Eastern Journal of Medicine. 2020; 25(2): 299 - 304. 10.5505/ejm.2020.21548 |
| IEEE | Oglak S,obut m "Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions." Eastern Journal of Medicine, 25, ss.299 - 304, 2020. 10.5505/ejm.2020.21548 |
| ISNAD | Oglak, Süleyman Cemil - obut, mehmet. "Comparison of Pap-smear and Colposcopy in the Absence of HPV Test for the Diagnosis of Premalignant and Malignant Cervical Lesions". Eastern Journal of Medicine 25/2 (2020), 299-304. https://doi.org/10.5505/ejm.2020.21548 |
